DE69918260D1 - Methoden zur Identifizierung und Validierung von funktionellen Zielen mittels Intrameren oder in vivo Selektion - Google Patents

Methoden zur Identifizierung und Validierung von funktionellen Zielen mittels Intrameren oder in vivo Selektion

Info

Publication number
DE69918260D1
DE69918260D1 DE69918260T DE69918260T DE69918260D1 DE 69918260 D1 DE69918260 D1 DE 69918260D1 DE 69918260 T DE69918260 T DE 69918260T DE 69918260 T DE69918260 T DE 69918260T DE 69918260 D1 DE69918260 D1 DE 69918260D1
Authority
DE
Germany
Prior art keywords
intramers
validation
identification
methods
vivo selection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69918260T
Other languages
English (en)
Other versions
DE69918260T2 (de
Inventor
Michael Blind
Michael Famulok
Waldemar Kolanus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69918260D1 publication Critical patent/DE69918260D1/de
Application granted granted Critical
Publication of DE69918260T2 publication Critical patent/DE69918260T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69918260T 1999-03-29 1999-03-29 Methoden zur Identifizierung und Validierung von funktionellen Zielen mittels Intrameren oder in vivo Selektion Expired - Fee Related DE69918260T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99106453A EP1041144B1 (de) 1999-03-29 1999-03-29 Methoden zur Identifizierung und Validierung von funktionellen Zielen mittels Intrameren oder in vivo Selektion

Publications (2)

Publication Number Publication Date
DE69918260D1 true DE69918260D1 (de) 2004-07-29
DE69918260T2 DE69918260T2 (de) 2005-07-14

Family

ID=8237883

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918260T Expired - Fee Related DE69918260T2 (de) 1999-03-29 1999-03-29 Methoden zur Identifizierung und Validierung von funktionellen Zielen mittels Intrameren oder in vivo Selektion

Country Status (8)

Country Link
US (1) US20070287153A1 (de)
EP (2) EP1041144B1 (de)
JP (1) JP2002539825A (de)
AT (1) ATE269897T1 (de)
AU (1) AU3558000A (de)
CA (1) CA2365297A1 (de)
DE (1) DE69918260T2 (de)
WO (1) WO2000058455A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1223216A1 (de) * 2000-12-30 2002-07-17 NascaCell GmbH Intrazelluläre Nukleinsäureinhibitoren kleiner Guaninnukleotid-Austauschfaktoren
US20130244239A1 (en) * 2010-04-01 2013-09-19 Nec Soft, Ltd. Nucleic acid construct and complex formation method and screening method using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707796A (en) * 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
WO1996038553A1 (en) * 1995-06-02 1996-12-05 M&E Biotech A/S A method for identification of biologically active peptides and nucleic acids
US6187757B1 (en) * 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
EP0877752B1 (de) * 1996-01-23 2003-05-21 The Board Of Trustees Of The Leland Stanford Junior University Verfahren zur suche nach transdominanten effektorpeptiden und rna-molekülen
WO1997039722A2 (en) * 1996-04-25 1997-10-30 T Cell Sciences, Inc. Method of isolating regulators of t cell activation
AU5927598A (en) * 1997-01-23 1998-08-18 Immusol Incorporated Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries

Also Published As

Publication number Publication date
EP1041144B1 (de) 2004-06-23
WO2000058455A3 (en) 2001-01-04
AU3558000A (en) 2000-10-16
ATE269897T1 (de) 2004-07-15
CA2365297A1 (en) 2000-10-05
US20070287153A1 (en) 2007-12-13
DE69918260T2 (de) 2005-07-14
WO2000058455A2 (en) 2000-10-05
EP1041144A1 (de) 2000-10-04
JP2002539825A (ja) 2002-11-26
EP1165770A2 (de) 2002-01-02

Similar Documents

Publication Publication Date Title
CY1116385T1 (el) Αντινοηματικη διαμορφωση της εκφρασης της απολιποπρωτεινης β
ATE302267T1 (de) Transgenes kaninchen, dass ein funktionelles menschliches lipoprotein(a) exprimiert
DE60323067D1 (de) Verfahren zur erzeugung doppelsträngiger dna mit einem 3'-einzelstranganteil und verwendungen dieser komplexe zur rekombination
ATE309536T1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
ATE514777T1 (de) Verbindungen und verfahren zur modulation von genexpression
ATE310812T1 (de) Derivate von zinkfingerproteinen und methoden
ATE364696T1 (de) Abc1 polypeptide und verfahren und reagenzien zur modulation des cholesterolgehalts
GB2348425B (en) Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to binds to preselected sites
DE69637395D1 (de) Moleküle, die sich in ausgewählten Organen oder Geweben in-vivo einfinden
EP1248794A4 (de) Antisens-modulierung der smad7 expression
DE69930765D1 (de) Methode zur kontrollierten verlängerung eines oligonukleotids
ATE405675T1 (de) Nukleinsäureliganden von tenascin-c
WO2003022222A3 (en) Antisense modulation of protein kinase r expression
ATE417930T1 (de) Proteinkinase npk-110
ATE534902T1 (de) Replikationsproteinn ciz1
HUP0402327A2 (hu) Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása
ATE269897T1 (de) Methoden zur identifizierung und validierung von funktionellen zielen mittels intrameren oder in vivo selektion
WO2004033485A3 (en) Nucleic acid supported protein complementation
ATE298246T1 (de) Aktiviertes protein c zur behandlung von pankreatitis
BRPI0506148A (pt) preparação farmacêutica para o tratamento de choque
DE60107888D1 (de) Beta-Interferon zur Behandlung von Immunerkrankungen
ATE214708T1 (de) Kationische mittel zur transfektion von nukleinsäuren
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
WO2001064876A3 (en) Human schizophrenia gene

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee